HOLD rating with $28.34 fair value vs $27.04 current price. Market leader in independent trustee services with 8.3% FCF yield, though regulatory overhang and fee compression limit upside.
View noteSTRONG SELL rating with 84% downside to $2.20 fair value. EBITDA margins compressing from 26.4% peak as competition intensifies.
View noteQuality gold producer with US$1,075/oz AISC trading at A$4.11 vs A$2.71 fair value. Strong operations, excessive valuation, 34% overvalued.
View notePayment processor trading at 42% discount to peers. Fair value $1.60 vs current $1.07. EBITDA margins recovering from 16.5% toward 26% through transformation programme.
View noteBUY rating with $1.83 fair value vs $0.93 current price. 38.3% EBITDA margins, 18.5% market share, trading at 63% discount to peers despite superior metrics.
View noteHOLD rating with $0.56 fair value vs $0.57 current price. Market leader in seniors' rental (18% share, 98% occupancy) executing risky all-age expansion. 35% execution failure probability creates binary outcomes.
View noteFair value $0.65 vs current $0.515. 30% EBITDA margins, 46% ROIC, but 89% international student dependency creates binary regulatory risk.
View noteECF trades at 31% discount to $1.02 fair value with 10.7% yield, 96.3% occupancy vs 94% peers, facing external management transition risks
View notePre-commercial cardiac device company with negative $(0.24) fair value. 77% revenue CAGR offset by permanent -178% EBITDA margins. 75% probability of value destruction versus 25% strategic acquisition hope.
View noteSELL rating with fair value $18.62 vs current $30.24. Healthcare distribution leader faces margin compression and direct distribution threats.
View noteSELL rating with fair value $4.71 vs current $7.42. Office REIT facing structural headwinds from hybrid working, 64% downside risk.
View noteHOLD rating with $2.39 fair value vs $2.80 current price. Exceptional 98.6% occupancy offset by development execution risks and overvaluation concerns.
View note